Cargando…
Pharmacogenomics of sickle cell disease: steps toward personalized medicine
Sickle cell disease (SCD) is a monogenetic disease but has a wide range of phenotypic expressions. Some of these differences in phenotype can be explained by genetic polymorphisms in the human globin gene. These polymorphisms can result in different responses to typical treatment, sometimes leading...
Autores principales: | Husain, Marium, Hartman, Amber D, Desai, Payal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5656342/ https://www.ncbi.nlm.nih.gov/pubmed/29089781 http://dx.doi.org/10.2147/PGPM.S123427 |
Ejemplares similares
-
Pharmacogenomics in osteoporosis: Steps toward personalized medicine
por: Greene, Robert, et al.
Publicado: (2009) -
Pharmacogenomics of anticoagulants: steps toward personal dosage
por: Daly, Ann K
Publicado: (2009) -
Pharmacogenomics in type II diabetes mellitus management: Steps toward personalized medicine
por: Avery, Peter, et al.
Publicado: (2009) -
Pharmacogenomics in cardiovascular disorders: Steps in approaching personalized medicine in cardiovascular medicine
por: Barone, Christopher, et al.
Publicado: (2009) -
Pharmacogenomics in Pediatric Patients: Towards Personalized Medicine
por: Maagdenberg, Hedy, et al.
Publicado: (2016)